The antisense and RNAi therapeutics market was valued at USD 5.10 Billion in 2024, driven by rising investments in genetic research and the growing prevalence of genetic disorders. Expected to grow at a CAGR of 18.70%, the market is projected to reach USD 28.32 Billion by 2034, reflecting increased adoption of advanced genetic therapies. https://www.expertmarketresearch.com/reports/antisense-and-rnai-therapeutics-market